Ambu

Ambu A/S is a Danish medical-technology company headquartered in Ballerup that develops, manufactures, and markets disposable and single-use devices for hospitals, private practices, emergency services, and other clinical settings. The company began in 1937 as Testa Laboratorium, founded in Denmark by German engineer Holger Hesse. Its early identity was closely associated with resuscitation and artificial-ventilation equipment, including the resuscitators that helped establish the Ambu name in emergency and critical-care practice. Over time, Ambu expanded from emergency-care products into anesthesia, airway management, patient monitoring, diagnostic electrodes, and neurophysiological testing. Its portfolio serves several clinical specialties, including anesthesia, cardiology, neurology, pulmonology, urology, and gastroenterology. The company’s products are used in operating rooms, intensive-care units, diagnostic departments, ambulances, rescue services, and private medical practices. International sales and distribution have been central to the business, with products marketed through subsidiaries and distributors across major healthcare markets. Ambu’s most important strategic shift has been the development of single-use endoscopy. The aScope platform helped establish the company as a prominent supplier of disposable bronchoscopes and other visualization tools for airway procedures. Rather than being cleaned and reprocessed between patients, single-use scopes are supplied sterile for one procedure. Ambu positions this model around infection-control considerations, simplified workflow, availability at the point of care, and the potential reduction of reprocessing-related costs and logistics. The strategy also reflects a broader transformation in medical devices toward procedure-specific, disposable technologies. The company strengthened its endoscopy position through acquisitions and product development. In 2013 it agreed to acquire King Systems, a United States-based manufacturer of single-use anesthesia and airway-management devices. In 2016 it acquired ETView Medical and its Vivasight airway products, which combine airway tubes with imaging capability for lung-isolation procedures. In 2017 Ambu acquired German company Invendo Medical, adding technology for single-use gastrointestinal endoscopy and extending its addressable market beyond pulmonary procedures. Ambu’s principal business areas are now generally described as Endoscopy Solutions and Anesthesia & Patient Monitoring. Endoscopy includes disposable bronchoscopes and related visualization systems, while anesthesia and patient monitoring includes ventilation and airway products, masks, electrodes, and diagnostic accessories. The company’s product architecture combines recurring procedure-based sales with clinical evidence, training, and hospital adoption programs. Its customers include healthcare professionals, procurement organizations, emergency responders, and medical institutions. Ambu is a publicly traded Danish company whose shares include the AMBU B class listed on Nasdaq Copenhagen. It remains active and internationally oriented. Its long-term positioning is built around making single-use medical devices available in more clinical procedures, particularly where disposable products may improve readiness, reduce reprocessing complexity, or support infection-prevention practices. The company’s historical progression—from resuscitation equipment to a broader disposable-medtech platform—defines its current brand identity.

Ambu traces its origins to 1937, when German engineer Holger Hesse established Testa Laboratorium in Denmark. The early company concentrated on equipment for resuscitation and artificial ventilation. These products addressed the needs of hospitals, rescue services, and emergency responders, and they gave Ambu a durable association with lifesaving care and practical clinical equipment. The company later broadened its medical-device activities. Its portfolio came to include anesthesia products, airway-management devices, patient-monitoring accessories, and diagnostic electrodes used in cardiology and neurophysiology. This diversification allowed Ambu to serve operating rooms, intensive-care departments, diagnostic units, ambulances, and private practices rather than relying on a single emergency-care category. The business developed an international sales structure using foreign subsidiaries and distributors. A defining stage in Ambu’s history was its move into single-use endoscopy. The Ambu aScope platform brought disposable visualization into airway procedures, particularly pulmonary and bronchoscopic applications. The model challenged the conventional dependence on reusable scopes, which require cleaning, disinfection, maintenance, storage, and availability planning. Ambu promoted single-use endoscopy as a way to provide a sterile device when needed while simplifying clinical logistics and supporting infection-control programs. Acquisitions accelerated this transition. In 2013 Ambu entered an agreement to acquire King Systems from Consort Medical. King manufactured single-use anesthesia and airway products in the United States, giving Ambu a stronger North American platform and a broader airway portfolio. In 2016 Ambu acquired ETView Medical, whose Vivasight products combined airway tubes with high-resolution imaging for lung-isolation procedures. This strengthened the company’s relevance to anesthesiology and thoracic surgery. In 2017 Ambu acquired Invendo Medical, a German developer of sterile single-use gastrointestinal endoscopy products. The transaction extended Ambu’s endoscopy strategy beyond the airways into gastroenterology and gastrointestinal surgery. Invendo’s technology included a disposable high-definition colonoscope platform, subject to the relevant regulatory clearances. The acquisition was presented as a major expansion of Ambu’s opportunity in single-use endoscopy. Ambu’s current business is organized around endoscopy solutions together with anesthesia and patient monitoring. Endoscopy remains a central growth platform, spanning pulmonary and other specialty applications, while the anesthesia and monitoring portfolio retains the company’s historical connection to airway management, ventilation, emergency care, and clinical diagnostics. Ambu continues to sell internationally to hospitals, private practices, and rescue organizations. The company’s strategic identity is therefore the result of two complementary developments: a long history in resuscitation and airway products, and a more recent effort to make disposable devices routine in procedures traditionally dependent on reusable equipment. Its brand promise centers on devices that are ready for use, designed for clinical workflows, and intended to support healthcare professionals in lifesaving and diagnostic work.

• 2017

  Invendo Medical acquisition

  [3]Ambu acquires Invendo Medical and enters market of 70 million gastro procedures annuallyglobenewswire.com

  Ambu acquired Invendo Medical to enter single-use gastrointestinal endoscopy and broaden its disposable endoscopy platform.

• 2016

  ETView Medical acquisition

  [5]Denmark’s Ambu pays $16m for ETView Medicalmassdevice.com

  Ambu added ETView Medical’s Vivasight airway-management and imaging products.

• 2013

  King Systems acquisition

  [4]Ambu enters agreement to acquire US-based King Systemsattachment.news.eu.nasdaq.com

  Ambu agreed to acquire King Systems, strengthening its single-use anesthesia and airway-management business in the United States.

• 1937

  Company founded as Testa Laboratorium

  [1]Ambuen.wikipedia.org

  Holger Hesse founded the Danish medical-device company that later became Ambu.

A clinical medical-device brand built around single-use technologies that support emergency care, airway management, diagnostic monitoring, and endoscopic procedures. Ambu emphasizes readiness, infection-control considerations, workflow efficiency, clinical utility, and the economic case for replacing selected reusable devices.

• Emergency care and artificial ventilation

  Ambu Resuscitators

  Ambu’s resuscitator family represents the company’s historic emergency-care business. These manual ventilation devices are designed to support patients who require assisted breathing in hospital, pre-hospital, and rescue settings. The range is associated with the Ambu brand’s early development and its long-standing focus on practical, lifesaving respiratory equipment.

• Single-use endoscopy

  Ambu aScope

  The aScope platform is a family of disposable endoscopic visualization systems, particularly associated with bronchoscopy and airway procedures. It is supplied for single-patient use rather than being reprocessed between procedures. Ambu presents the platform as a way to improve immediate availability, simplify workflow, and reduce dependence on reusable-scope cleaning and maintenance infrastructure.

• Airway management and imaging

  Vivasight

  Originally developed by ETView Medical, Vivasight products combine airway tubes with integrated imaging capability. They are intended to help clinicians visualize airway conditions during procedures such as lung isolation, with applications in anesthesiology and thoracic surgery. Ambu added the portfolio through its acquisition of ETView Medical.

• Patient monitoring and diagnostics

  Single-use electrodes

  Ambu produces disposable electrodes used in cardiological examinations, ECG testing, and neurophysiological mapping. These products extend the company’s single-use approach beyond endoscopy and support diagnostic and monitoring workflows in hospitals and clinical practices.

• 2024Cost of Reprocessing

  Global

  A reported campaign supporting single-use endoscopy adoption by comparing the total cost and operational burden of reusable scopes with disposable alternatives. The campaign used educational content and an online savings calculator aimed at hospital decision-makers.

  Outcome. The cited marketing analysis reports that the calculator generated more than 15,000 savings reports, but independently verified commercial impact is not available in the supplied sources.

  Source
• aScope global rollout

  Global

  Ambu has supported the international adoption of the aScope family through clinical education, targeted hospital engagement, product demonstrations, and evidence focused on workflow and infection-control considerations.

  Source

• 2017

  Acquisition of Invendo MedicalM&A

  Background

  Ambu wanted to extend its single-use endoscopy strategy from pulmonary procedures into gastroenterology and gastrointestinal surgery.

  Action taken

  Ambu acquired Invendo Medical and its disposable gastrointestinal endoscopy technology.

  Aftermath

  Ambu entered the single-use gastrointestinal endoscopy market and added a disposable high-definition colonoscope platform subject to regulatory clearances.

  Purchase price. EUR 115 million upfront plus contingent payments of up to EUR 110 million (Announced October 2017)

  Source

• 2016

  Acquisition of ETView MedicalM&A

  Background

  Ambu aimed to strengthen its airway-management offering with imaging-enabled products for lung-isolation procedures.

  Action taken

  Ambu acquired ETView Medical and its Vivasight product line.

  Aftermath

  The acquisition broadened Ambu’s relevance to thoracic surgery and anesthesiology.

  Reported transaction value. USD 16 million (Announced June 2016)

  Source

• 2012

  Agreement to acquire King SystemsM&A

  Background

  Ambu sought to expand its single-use anesthesia and airway-management business and strengthen its United States presence.

  Action taken

  Ambu signed a conditional agreement to acquire King Systems from Consort Medical.

  Aftermath

  The transaction provided Ambu with a broader airway portfolio and a US manufacturing and commercial platform.

  Purchase price. USD 120 million plus potential milestone payments of up to USD 50 million (Announced December 2012)

  Source

• 2020.06.15

  Ambu appoints Dave Rawlings as marketing director[7]Ambu任命Dave Rawlings为营销总监dc.citybuzz.co

  Ambu named Dave Rawlings as Director of Marketing for its core product lines, including anesthesiology, EMS, and patient monitoring and diagnostics.

Read more

1. 1Ambuen.wikipedia.org
2. 2Ambu official websiteambu.com
3. 3Ambu acquires Invendo Medical and enters market of 70 million gastro procedures annuallyglobenewswire.com
4. 4Ambu enters agreement to acquire US-based King Systemsattachment.news.eu.nasdaq.com
5. 5Denmark’s Ambu pays $16m for ETView Medicalmassdevice.com
6. 6Cost of Reprocessingportersfiveforce.com
7. 7Ambu任命Dave Rawlings为营销总监dc.citybuzz.co